Sareum Holdings (SAR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

21.00p
   
  • Change Today:
      1.25p
  • 52 Week High: 37.00
  • 52 Week Low: 11.25
  • Currency: UK Pounds
  • Shares Issued: 134.41m
  • Volume: 773,685
  • Market Cap: £28.23m
  • RiskGrade: 594
  • Beta: 0.06

Sareum Holdings Overview

Sareum discovers and develops innovative drug candidates aimed at cancers and autoimmune diseases. Our drug development programmes aim to improve outcomes for patients with serious medical conditions and where current therapies are inadequate.

1 Day Chart (04-07-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 13.4  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Sareum Holdings Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 0.05 (1.12) (1.50)p n/a n/a n/a n/a 0.0%
30-Jun-21 n/a (1.72) (2.30)p n/a n/a n/a n/a 0.0%
30-Jun-22 n/a 2.58 (3.20)p n/a n/a n/a n/a 0.0%
30-Jun-23 n/a (4.03) (4.70)p n/a n/a n/a n/a 0.0%
30-Jun-24 n/a (4.60) (4.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Sareum Holdings Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 n/a (3.76) (2.22)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Sareum Holdings Company Announcements

Appointment of Sole Broker 04-Jul-2025 07:00 RNS
Initiation of Toxicology Studies for SDC-1801 29-May-2025 07:00 RNS
Update on TYK2/JAK1 and SRA737 Programmes 28-Apr-2025 07:00 RNS

Latest Sareum Holdings Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Sareum Holdings Market Data

Currency UK Pounds
Share Price 21.00p
Change Today 1.25p
% Change 6.33 %
52 Week High 37.00
52 Week Low 11.25
Volume 773,685
Shares Issued 134.41m
Market Cap £28.23m
Beta 0.06
RiskGrade 594

Sareum Holdings Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.01% below the market average46.01% below the market average46.01% below the market average46.01% below the market average46.01% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
78.13% below the market average78.13% below the market average78.13% below the market average78.13% below the market average78.13% below the market average
60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average60.87% below the sector average
Income Not Available
Growth Not Available

Sareum Holdings Dividends

No dividends found

Trades for 04-Jul-2025

Time Volume / Share Price
16:28 22,634 @ 20.25p
16:27 20,000 @ 20.00p
16:23 725 @ 21.36p
16:19 30,000 @ 22.00p
16:17 2,532 @ 20.22p

Sareum Holdings Key Personnel

COO Timothy J Mitchell

Top of Page